Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  API >  Circulatory system drugs >  Antiarrhythmics Drugs >  Pilsicainide hydrochloride

Pilsicainide hydrochloride

Basic information Safety Supplier Related

Pilsicainide hydrochloride Basic information

Product Name:
Pilsicainide hydrochloride
Synonyms:
  • Pilzicainide hydrochloride
  • Rizumcote
  • Tatsupilljin
  • Pilsicainide-Hydrochlordie
  • N-(2,6-Dimethylphenyl)-2-(hexahydro-1H-pyrrolizin-7a-yl)acetamide hydrochloride
  • n-(2,6-dimethylphenyl)-2-(1,2,3,5,6,7-hexahydropyrrolizin-8-yl)acetamide hydrochloride
  • PILSICAINIDE HYDROCHLORIDE
  • PILSICAINIDE HYDROCHLORIDE HEMIHYDRATE
CAS:
88069-49-2
MF:
C17H24N2O
MW:
272.39
Mol File:
88069-49-2.mol
More
Less

Pilsicainide hydrochloride Chemical Properties

Melting point:
212-214°
storage temp. 
room temp
solubility 
Chloroform (Slightly), Water (Slightly)
form 
powder
color 
white to beige
More
Less

Safety Information

RIDADR 
UN 2811 6.1 / PGIII
WGK Germany 
3
HS Code 
2933.99.7000
Toxicity
LD50 in mice (mg/kg): 410 s.c. (Miyano, 1985)
More
Less

Pilsicainide hydrochloride Usage And Synthesis

Description

Pilsicainide hydrochloride is a new pynolizidine lidocaine derivative with antiarrhythmic activity. It is the first pharmaceutical product introduced by Suntory and was solely developed in Japan. The compound is reported to be highly effective in the treatment of premature ventricular contraction. It has no anticholinergic or CNS activity and is not as likely as other class 1C antiarrhythmics to have restricted indications.

Originator

Suntory (Japan)

Uses

Pilsicainide hydrochloride has been used as a sodium channel blocker:

  • to study its effects on electrophysiological parameters in guinea pig pulmonary vein preparation
  • to study its effects on Ca2+?release and arrhythmic events in Andersen-Tawil syndrome induced pluripotent stem cells (ATS-iPSC)-derived cardiomyocytes
  • to study its electrophysiological effects on the guinea pig atrium

brand name

Sunrhythm

Biochem/physiol Actions

Pilsicainide hydrochloride is a pure sodium channel blocker and an open channel blocker of Na+1 channels. Pilsicainide was defined as a pure sodium channel blocker. The compound is classified as a class Ic antiarrhythmic drug, and was originally developed in Japan. Similar to Lidocaine, Pilsicainide binds to open channels, but slowly. Pilsicainide is capable of selectively blocking the late currents in the mutant Na(+) channels that show dominant abnormal burst openings such as in δKPQ mutants. The compound is used to induce Brugada syndrome (BS) in animal models.

Pilsicainide hydrochlorideSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Chembest Research Laboratories Limited
Tel
021-20908456
Email
sales@BioChemBest.com
Pure Chemistry Scientific Inc.
Tel
001-857-928-2050 or 1-888-588-9418
Email
sales@chemreagents.com
LGM Pharma
Tel
1-(800)-881-8210
Email
inquiries@lgmpharma.com
Shanghai Hanhong Scientific Co.,Ltd.
Tel
021-54306202 13764082696;
Email
info@hanhongsci.com